-
Crown Biosciences Opens Facility in China
contractpharma
November 06, 2020
Crown Bioscience, a JSR Life Sciences company, has opened a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand.
-
CDMO Minaris Invests $64.5M to Expand Operations
contractpharma
November 05, 2020
To significantly expand manufacturing capacity for cell and gene therapies in Germany and Japan.
-
Aphena Pharma Completes $7M Expansion
americanpharmaceuticalreview
November 05, 2020
Aphena Pharma Solutions has completed its $7 million facility expansion and renovation in Easton, Maryland. The newly renovated, 30,000-square-foot facility and three large, high-end blending suites are open for new pharmaceutical business.
-
Minaris Invests $64.5M to Expand Cell and Gene Mfg. Facilities
contractpharma
November 04, 2020
New buildings near Munich, Germany and Yokohama, Japan will more than double capacity for commercial manufacturing of regenerative medicines.
-
Samsung Biologics Expands Global Footprint
contractpharma
November 02, 2020
Samsung Biologics has opened its first U.S. CDO R&D Center in San Francisco, CA, bringing its contract development services closer to global clients.
-
Aphena Pharma Completes $7M Facility Expansion
contractpharma
October 29, 2020
Newly renovated, 30,000-sq.-ft. facility and three large blending suites support liquids, creams, gels and suspensions.
-
JSR Life Sciences Expands European Footprint
contractpharma
October 22, 2020
JSR Life Sciences, LLC is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA.
-
Telstar’s centre in the UK consolidates its business growth with move to new higher-capacity modern installation
europeanpharmaceuticalreview
October 21, 2020
Specialised in aseptic and containment barrier Isolation technology systems, Telstar UK has seen increased demand for its products from all across the life sciences sector has grown significantly in the past few years.
-
GSK to Sell Poznań Manufacturing Site to Delpharm
contractpharma
October 16, 2020
The CDMO acquires all facilities and around 700 manufacturing employees.
-
FDB Approves Argonaut’s Facility
contractpharma
October 15, 2020
The California Department of Public Health, Food and Drug Branch (FDB) has inspected and approved Argonaut Manufacturing Services’ new Drug Product Manufacturing facility, permitting Argonaut to manufacture and ship pharmaceutical products.